Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 1994

Conditions
Toxoplasmosis, CerebralHIV Infections
Interventions
DRUG

Pyrimethamine

DRUG

Leucovorin calcium

Trial Locations (24)

10003

Beth Israel Med. Ctr. (Mt. Sinai), New York

10016

NY Univ. HIV/AIDS CRS, New York

10021

Cornell University A2201, New York

Memorial Sloan-Kettering Cancer Ctr., New York

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

14642

Univ. of Rochester ACTG CRS, Rochester

15213

Pitt CRS, Pittsburgh

21287

Johns Hopkins Adult AIDS CRS, Baltimore

27599

Unc Aids Crs, Chapel Hill

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

33136

Univ. of Miami AIDS CRS, Miami

44106

Case CRS, Cleveland

45267

Univ. of Cincinnati CRS, Cincinnati

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

55455

University of Minnesota, ACTU, Minneapolis

60611

Northwestern University CRS, Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

90502

Harbor-UCLA Med. Ctr. CRS, Torrance

94304

Stanford CRS, Palo Alto

Unknown

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Washington U CRS, St Louis

02118

Bmc Actg Crs, Boston

07103

NJ Med. School CRS, Newark

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH